J Am Pharm Assoc (2003)
-
Publication Venue For
- Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence.. 62:1321-1328.e3. 2022
- Impact of a clinical pharmacist on provider prescribing patterns in a primary care clinic.. 62:209-213.e1. 2022
- Impact of pharmacist outreach on glucagon prescribing.. 62:1384-1388.e1. 2022
- Reducing high-risk medication use through pharmacist-led interventions in an outpatient setting.. 60:e86-e92. 2020
- The possible harms of statins: What do product labels, patient package inserts, and pharmacy leaflets tell us?. 59:195-201. 2019
- Pharmacists' experience with prescribing hormonal contraception in Oregon.. 58:608-613. 2018
- Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.. 56:521-526. 2016
- Community pharmacists' experience with pharmacogenetic testing.. 55:587-594. 2015
- Health care providers' use of a drug information service for pregnancy-related inquiries.. 54:502-509. 2014
- Implementation of a pharmacogenomics service in a community pharmacy.. 54:172-180. 2014
- Factors affecting Medicare Part D beneficiaries' decision to receive comprehensive medication reviews.. 53:482-487. 2013
- Making pharmacogenetic testing a reality in a community pharmacy.. 52:e259-e265. 2012
- Safety-focused medication therapy management: a randomized controlled trial.. 52:603-612. 2012